COX2 selective NSAIDs and renal function: Gain without pain?

被引：13
|
作者：
Breyer, MD [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37240 USA
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 02期
关键词：
cyclooxygenase; inflammation; toxicity; hemodynamics; analgesic nephropathy;
D O I：
10.1046/j.1523-1755.1999.00333.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：738 / 739
页数：2
相关论文
共 50 条
  • [1] Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risks
    Brophy, James M.
    [J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 586 - 587
  • [2] Vascular events with selective COX2 inhibitors and NSAIDs: analyzing the risks
    James M Brophy
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 586 - 587
  • [3] Selective targeting of COX1 and COX2 reveals opposite effects on blood pressure and renal function.
    Qi, ZH
    Redha, R
    Hao, CM
    Morrow, JD
    Langenbach, RL
    Breyer, MD
    [J]. FASEB JOURNAL, 2002, 16 (05): : A1171 - A1171
  • [4] COX-2 selective NSAIDS
    Ryan, NS
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2000, 67 (01) : 67 - 67
  • [5] Control of cardiovascular and renal function through COX1 and COX2 derived prostanoids
    Breyer, Matthew D.
    Hao, Chuanming
    Schneider, Andre
    Qi, Zhonghua
    Guan, Youfei
    Zhang, Yahua
    Breyer, Richard M.
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 45 - 45
  • [6] COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
    Cheng, I.
    Liu, X.
    Plummer, S. J.
    Krumroy, L. M.
    Casey, G.
    Witte, J. S.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (04) : 557 - 561
  • [7] COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
    I Cheng
    X Liu
    S J Plummer
    L M Krumroy
    G Casey
    J S Witte
    [J]. British Journal of Cancer, 2007, 97 : 557 - 561
  • [8] Selective induction of COX2 expression in renal medullary interstitial cell injury.
    Hao, CM
    Redha, R
    Breyer, MD
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2804 - A2804
  • [9] Gastrointestinal safety of COX2 inhibitors might be no better than that of nonselective NSAIDs
    Rachel Murphy
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (4): : 176 - 176
  • [10] NSAIDs: gastroprotection or selective COX-2 inhibitor?
    Dickman, A
    Ellershaw, J
    [J]. PALLIATIVE MEDICINE, 2004, 18 (04) : 275 - 286
12345